Phoebe Ryan
Overview
Explore the profile of Phoebe Ryan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
9
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bardia A, Sun S, Thimmiah N, Coates J, Wu B, Abelman R, et al.
Clin Cancer Res
. 2024 May;
30(14):2917-2924.
PMID: 38709212
Purpose: The antibody-drug conjugate (ADC) sacituzumab govitecan (SG) comprises the topoisomerase 1 (TOP1) inhibitor (TOP1i) SN-38, coupled to a monoclonal antibody targeting trophoblast cell surface antigen 2 (TROP-2). Poly(ADP-ribose) polymerase...
2.
Oladeru O, Dunn S, Li J, Coles C, Yamauchi C, Chang J, et al.
JCO Glob Oncol
. 2023 Jul;
9:e2300010.
PMID: 37471670
Purpose: The COVID-19 pandemic has profoundly affected cancer care worldwide, including radiation therapy (RT) for breast cancer (BC), because of risk-based resource allocation. We report the evolution of international breast...
3.
Medford A, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, et al.
Ther Adv Med Oncol
. 2023 Feb;
15:17588359231152844.
PMID: 36743521
Tissue-agnostic indications for targeted therapies have expanded options for patients with advanced solid tumors. The Food and Drug Administration approvals of the programmed death-ligand 1 inhibitor pembrolizumab and the TRK...